Commercial albumin preparations contain HDL-like lipid-protein complexes that may introduce exogenous effects in in vitro studies of lipoprotein metabolism.
No takes yet. Share an insight, caveat, or question.
May introduce exogenous HDL-like particles in albumin-based in vitro assays; leaves open effects on prior lipoprotein metabolism findings.
Fainaru et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: